MGIC: Buy The Tortoise Instead Of The Hare

MGIC Investment Corporation is rated a Buy due to its undervalued stock price and low investor attention. Learn more about ...

Cogent Biosciences, Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors Transcript

Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...

Altaira Launches Alpha+ and Krell+ to Deliver Measurable "Operational Alpha" and Reduce Fund Managers' Fixed Costs

Altaira Strategic Partners, LLC, a provider of institutional-grade back and middle office solutions for investment funds, is expanding its platform with two new offerings: Alpha+ and Krell+. Combined, ...